Trimoryn Reference Guides: Two Longer Pieces

Most of what is written about supplements is written to sell one. The government pages that are not, the NIH fact sheet on weight-loss supplements, the NCCIH page on weight control and its guidance on using supplements wisely, are excellent and are linked throughout this website. They are also written for a reader who already knows what a Daily Value is.

These two pages sit between the two. They assume nothing, they explain the vocabulary a panel uses, and they end with a checklist a reader can take to any bottle including this one. Somebody who reads both and buys a different product has been served, which is the test a reference page has to pass to be worth publishing at all.

Read left to right if you are new to this category and right to left if you already know it and want this bottle assessed.

Three routes through, and none of them is long.

• If you are deciding whether to buy anything in this aisle at all, start with the category guide, then read the three government pages it links: the NIH fact sheet on weight-loss supplements, the NCCIH page on weight control, and its guidance on using supplements wisely. Those three are written by people with nothing to sell and they will do more for your expectations than any commercial page, this one included.
• If you have a specific bottle in front of you, go straight to the twelve-row checklist and apply it. It takes about five minutes with the label in hand and it works on any product in this category.
• If you are deciding about this product specifically, read the checklist scoring first, because it is where the three failures are, and then the dosage comparison, because that is where the arithmetic behind them is.

The journal takes single questions from this label and follows each one as far as the published work goes. It is linked from its own index and four of its five pieces end on a number that does this product no favours.

None of these four is written to sell anything and all four are free. A reader who reads them and buys nothing has still been served, which is the test a reference page has to pass.

• The NIH fact sheet on weight-loss supplements goes ingredient by ingredient through the whole category and is candid about how thin most of the evidence is.
• The NCCIH page on weight control is the shorter overview and the best starting point for somebody who has never read either.
• NCCIH on using dietary supplements wisely makes the point that matters most in practice: the risk usually comes from several supplements bought separately rather than from any one of them.
• The NIH consumer sheet on dietary supplements explains what the regulatory framework does and does not guarantee, which is the single most misunderstood thing in this aisle.

Two more are worth knowing about for the specific hazard in this category. The FDA maintains a warning about products marketed as supplements that carry undeclared prescription drugs, and weight loss is one of the three categories where that happens most. The FTC sets out the shapes weight-loss advertising takes, including the before-and-after photograph and the struck-through comparison price.

• Whether a particular product contains what its label says. That needs an assay per lot, by somebody with no stake in the answer. No guide can substitute for it and no seal on any packaging is one.
• Whether anything will work for you. The pooled effects across this whole category are small with wide intervals. A guide can tell you what the average was; it cannot tell you where in the distribution you will land, and anybody claiming otherwise is selling something.
• Whether a supplement is safe with your prescription. A guide can name the ingredient with the pharmacology attached to it, which on this panel is berberine. The answer for one person needs somebody who knows what that person takes.

Those three are the reason a long money-back window matters more than any label claim. It is the only mechanism by which a buyer can find out something a document cannot tell them, and it is why row eleven of the checklist is worth more than two marginal passes elsewhere.

Neither guide carries a price, a stock figure or anything else that moves weekly, which is deliberate: a reference page that goes out of date every month is not a reference page. What will change them is new evidence or a corrected error.

Three things would trigger a rewrite. A published trial of a finished multi-ingredient formula in this category, which does not currently exist anywhere. A change to what a label in this category is required to print, which would change several of the twelve rows at once. Or a reader pointing out that something here is wrong, which is the likeliest of the three and the most welcome.

The review date at the foot of every page moves whenever any page changes, so a reader can tell at a glance how recently either guide was looked at.